All-In with Chamath, Jason, Sacks & Friedberg cover image

Inside the GLP-1 Gold Rush: Eli Lilly CEO on New Breakthroughs, Addiction & Mental Health, Pricing

All-In with Chamath, Jason, Sacks & Friedberg

00:00

Early GLP-1 Research and Terzepatide Breakthrough

Dave Ricks recounts Lilly's 2006 GLP-1 launch, iterative improvements, and the 2014 discovery leading to tirzepatide (Mounjaro).

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app